• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Using Technology for Early Detection of LEMS

Opinion
Video

A panelist discusses how enhanced screening protocols combined with predictive analytics can accelerate Lambert-Eaton myasthenic syndrome (LEMS) detection in high-risk populations like patients with small cell lung cancer (SCLC) while also exploring the potential of telemedicine to improve early diagnosis in underserved communities.

Video content above is prompted by the following:

  • How can improved screening protocols and the integration of predictive analytics in clinical practice enhance early detection of LEMS in high-risk patients, such as those with SCLC, and which patient populations should be prioritized?
  • In what ways can telemedicine and digital health tools support earlier detection of LEMS, especially in underserved areas?
Related Videos
1 expert is featured in this series.
5 experts are featured in this series.
5 experts are featured in this series
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.